Ka
Karuna (BMS)
Boston MAFounded 2009800 employees
Private CapbiotechAcquiredCNS
Platform: Muscarinic
Market Cap
N/A
All Drugs
3
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| KAR-3569 | KAR-3569 | NDA/BLA | 1 | CDK2 | MMAML | ||
| Polatinib | KAR-1513 | Phase 1 | 1 | PARP | PBCOvarian Ca | ||
| Sotofutibatinib | KAR-8988 | Phase 1/2 | 2 | KRASG12D | Myelofibrosis |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (3)